XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Collaborations and Other Arrangements - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Baqsimi        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Proceeds from sale of product rights $ 500.0      
Additional cash proceeds 125.0 $ 125.0   $ 125.0
Milestone payment received $ 450.0 450.0   450.0
Revenue recognized   $ 579.0   $ 579.0
Royalty Agreement Terms | Olumiant®        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Collaborative arrangement, rights and obligations percent (up to)     20.00%  
Milestone Payments, Sales-based | Olumiant®        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential achievements     $ 100.0  
Milestone Payments, Sales-based | Ebglyss        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential achievements     1,250.0  
Milestone Payments, Sales-based | Ebglyss | Roche        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential achievements     1,030.0  
Milestone Payments, Sales-based | Orforglipron | Chugai        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential achievements     250.0  
Milestone Payments, Development and Regulatory | Ebglyss | Roche        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential achievements     100.0  
Milestone Payments, Development and Regulatory | Orforglipron | Chugai        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential achievements     $ 140.0